Spectrums of amyotrophic lateral sclerosis: heterogeneity, pathology, and therapeutic directions /

"Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disorder affecting both upper and lower motor neurons. Based on age at onset, site of onset, disease duration, and relative predominance of upper or lower motor neuron signs, clinical manifestations of ALS are very hetero...

Full description

Saved in:
Bibliographic Details
Corporate Authors: Wiley Online Library (Online service)
Group Author: Shaw, Christopher A. (Christopher Ariel); Morrice, Jessica R.
Published: Wiley-Blackwell,
Publisher Address: Hoboken, NJ :
Publication Dates: 2021.
Literature type: eBook
Language: English
Subjects:
Online Access: https://onlinelibrary.wiley.com/doi/book/10.1002/9781119745532
Summary: "Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disorder affecting both upper and lower motor neurons. Based on age at onset, site of onset, disease duration, and relative predominance of upper or lower motor neuron signs, clinical manifestations of ALS are very heterogeneous, and different clinical subtypes may be delineated. Although ALS has long been considered a paradigm of pure motor neuron disorder, it has recently been linked to other neurological diseases. Clinical, genetic, and/or neuropathological overlap exists with frontotemporal dementia, distal myopathies, psychiatric disorders, and extrapyramidal syndromes. This clinical heterogeneity can depend on the pleiotropy of ALS-associated genes and by the oligogenic model of disease mechanism. A number of animal models have been created, each of them recapitulating some clinical and neuropathological features of patients. More recently, induced pluripotent stem cells have been used, directly derived from affected patients with different genetic mutations. The combination of animal and cellular models represents an advanced tool that can help to functionally characterize the pathogenetic mechanisms underlying the disease and specifically find efficient and personalized drugs to treat ALS patients"--
Item Description: Description based on print version record.
Carrier Form: 1 online resource (240 pages)
Also available in print.
Bibliography: Includes bibliographical references and index.
ISBN: 9781119745532 (electronic bk.)
9781119745495
Index Number: RC406
CLC: R746.4